Navigation Links
GenoVive, a pioneer in DNA-based weight management solutions, today announced the company's first European partnership as of May 1, 2013 with DNADIETA based in Poland.

NEW ORLEANS, May 14, 2013 /PRNewswire/ -- GenoVive is forming worldwide partnerships and is engaged in discussions with several countries in Europe and other continents to bring its "Weight Loss Designed by Science" program internationally.  Vic Castellon , PhamD. CEO and Founder of GenoVive ( states, "This partnership with DNADIETA brings GenoVive's innovative approach to weight loss and health optimization to Europe.  The technology uniquely identifies the genetic make-up of an individual; that is the basis for customized diet, exercise plans and education to the client to optimize weight loss and manage it, by encouraging and educating the client on a positive lifestyle change. The proprietary genetic test panel is backed by over twenty-five interventional human clinical trials, from prestigious Ivy League universities in the United States and the European Continent.

DNADIETA brings the innovation of personalized health to Poland. As people in Poland continue to realize the harmful effects of obesity, GenoVive and DNADIETA remain committed to furthering the development of long-term and comprehensive solutions to weight management based on the individual's genetics and personalized nutrition and exercise.  This new approach to diet and exercise makes use of the latest advances in the field of nutrigenomics, which is the study of the effects of foods on gene expression and the role certain genes play in our health.

Dariusz Pełka, CEO and Founder of DNADIETA ( brings this innovative technology to Poland commenting, "This new DNA-based service achieves success through effective and innovative diet and exercise programs and supplements based on analysis of DNA samples and on additional data such as height, weight and gender.  The DNA sample for these tests is conveniently obtained through the mail by way of a simple swabbing of the inner cheek."

GenoVive is already enjoying international success in locations such as Mexico and the Dominican Republic.  "GenoVive's innovative approach to weight loss based on DNA analysis and all-natural meal programs has already resonated tremendously with our patients in Mexico City," said Tatiana Palazuelos , R.D., with Bariatric Support. " program complements our holistic and comprehensive approach to weight loss which includes physician visits and oversight, plus nutrition and psychological counseling. We look forward to growing the partnership to benefit our patient base who desire customized weight loss programs that will work for the long term."

GenoVive is very excited with the most recent partnership with Poland.  Together with DNADIETA, GenoVive is working hard to offer cutting edge technology to assist individuals in leading a healthier lifestyle based on genetic, personalized nutrition and exercise.

For additional information or with questions contact Paul Clinkscales (, 504-734-3030,

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
2. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
3. Oxitec Recognised by Prestigious Frost and Sullivan Award for its Pioneering System of Pest Control
4. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
5. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
6. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
7. Society for Brain Mapping and Therapeutics endorse President Obamas support for Human Brain Mapping research; nominating him for prestigious Pioneer in Healthcare Policy Award
8. ALCAT Pioneer, Roger Deutsch, to Address "Food Allergies and Intolerances" at the Institute of Functional Medicine Conference in Tampa, February 8-10
9. DuPont Pioneer Launches Next Generation T Series Soybeans
10. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
11. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
Post Your Comments:
(Date:11/30/2015)... JACKSONVILLE, Florida , November 30, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, today announced it will be presenting ... Event on December 1, 2015 at 2.30 PM PT. ... member and Strategic Advisor will be giving the presentation ...
(Date:11/30/2015)... Md. , Nov. 30, 2015  Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... adding an additional independent director, and the Company welcomes ... of allegations in a recent anonymous internet report on ... both initiatives. Linda Powers stated, "We ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... that includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, ... spectroscopy, covers a wide range of applications such as, but not limited to, ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
Breaking Biology Technology:
(Date:10/26/2015)... and LAS VEGAS , Oct. ... Labs , an innovator in modern authentication and a ... announced the launch of its latest version of the ... enabling organizations to use standards-based authentication that supports existing ... S3 Authentication Suite is ideal for organizations deploying customer-facing ...
(Date:10/23/2015)... , Oct. 23, 2015 Research and ... the "Global Voice Recognition Biometrics Market 2015-2019" ... --> The global voice recognition biometrics ... 2014-2019. --> --> ... has been prepared based on an in-depth market analysis ...
(Date:10/22/2015)... 22, 2015  Aware, Inc. (NASDAQ: AWRE ), a leading ... its third quarter ended September 30, 2015.  ... 2015 was $4.0 million, a decrease of 33% compared to $6.0 ... third quarter of 2015 was $2.2 million, or $0.10 per diluted ... in the same period a year ago.  ...
Breaking Biology News(10 mins):